Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor | Patent Number 11590128

US 11590128 B2
Application Number17834709
Publication NumberUS 20220370441 A1
Pendency8 months, 26 days
Filled DateJun 7, 2022
Priority DateSep 7, 2012
Publication DateNov 24, 2022
Expiration DateSep 6, 2032
Inventor/ApplicantsChristian Klein
Rod A. Humerickhouse
Andrew W. Roberts
Deepak Sampath
Sari L. Heitner Enschede
John F. Seymour
Wayne John Fairbrother
ExaminesXIAO, YAN
Art Unit1642
Technology Center1600
Assignments
Roche
Current
Abbvie Inc.
Current
Genentech IncRoche
Original
Abbvie Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.